Boston Scientific Corporation
BSXLast close · Oct 16, 202644.39+0.25 (+0.57%)
Market cap$64.3B
Between May 2, 2026 and Sep 2, 2026, Boston Scientific (BSX) insiders filed 40 Form 4 transactions: no sale and 10 open-market purchases worth $10.0M. 30 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
10
0
0
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | O'Connor Padraig Andrew | EVP, Global Operations | M | 1,171 | 0.00 | $0 | |
| 2026-09-02 | O'Connor Padraig Andrew | EVP, Global Operations | F | 567 | 48.37 | $27,425.8 | |
| 2026-09-02 | O'Connor Padraig Andrew | EVP, Global Operations | M | 1,171 | 0.00 | $0 | |
| 2026-08-25 | Morano Susan E | Director | P | 2,040 | 49.22 | $100,407.8 | |
| 2026-08-11 | Woodworth Emily | SVP, Global Controller and CAO | I | 2,930 | 51.19 | $149,986.7 | |
| 2026-08-10 | Monson Jonathan | EVP and CFO | I | 9,908 | 50.46 | $499,957.7 | |
| 2026-08-05 | Habiger David C | Director | P | 2,100 | 47.59 | $99,936.9 | |
| 2026-08-03 | Habiger David C | Director | P | 1,042 | 48.07 | $50,084.3 | |
| 2026-08-04 | Habiger David C | Director | P | 140 | 48.59 | $6,802.3 | |
| 2026-08-03 | Mahoney Michael F | Chairman, President & CEO | P | 186,240 | 48.33 | $9.0M | |
| 2026-08-03 | Mahoney Michael F | Chairman, President & CEO | I | 22,119 | 48.43 | $1.1M | |
| 2026-07-31 | LUDWIG EDWARD J | Director | P | 5,000 | 45.48 | $227,399.5 | |
| 2026-07-31 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | I | 64,198 | 46.73 | $3.0M | |
| 2026-07-01 | Monson Jonathan | EVP and CFO | M | 2,087 | 0.00 | $0 | |
| 2026-07-01 | Monson Jonathan | EVP and CFO | F | 1,010 | 43.06 | $43,490.6 | |
| 2026-07-01 | Monson Jonathan | EVP and CFO | M | 2,087 | 0.00 | $0 | |
| 2026-05-28 | Mahoney Michael F | Chairman, President & CEO | G | 386,755 | 0.00 | $0 | |
| 2026-05-20 | Pegus Cheryl | Director | P | 1,770 | 56.49 | $99,987.3 | |
| 2026-05-20 | LUDWIG EDWARD J | Director | P | 3,580 | 56.68 | $202,914.4 | |
| 2026-05-20 | Habiger David C | Director | P | 2,250 | 55.92 | $125,818.9 | |
| 2026-05-19 | Habiger David C | Director | P | 2,200 | 56.95 | $125,279.2 | |
| 2026-05-07 | Zane Ellen M | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | WICHMANN DAVID S | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | Weber Christophe Pierre | Director | A | 2,660 | 0.00 | $0 | |
| 2026-05-07 | Weber Christophe Pierre | Director | A | 1,767 | 0.00 | $0 | |
| 2026-05-07 | Weber Christophe Pierre | Director | A | 1,140 | 0.00 | $0 | |
| 2026-05-07 | Smith Cathy R | Director | A | 2,209 | 0.00 | $0 | |
| 2026-05-07 | Smith Cathy R | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | Pegus Cheryl | Director | A | 1,281 | 0.00 | $0 | |
| 2026-05-07 | Pegus Cheryl | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | Morano Susan E | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | Morano Susan E | Director | A | 1,281 | 0.00 | $0 | |
| 2026-05-07 | Mega Jessica L | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | LUDWIG EDWARD J | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-07 | Habiger David C | Director | A | 3,800 | 0.00 | $0 | |
| 2026-05-02 | O'Connor Padraig Andrew | EVP, Global Operations | M | 1,802 | 0.00 | $0 | |
| 2026-05-02 | O'Connor Padraig Andrew | EVP, Global Operations | F | 872 | 56.50 | $49,268 | |
| 2026-05-02 | O'Connor Padraig Andrew | EVP, Global Operations | M | 1,802 | 0.00 | $0 | |
| 2026-05-02 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | 2,102 | 0.00 | $0 | |
| 2026-05-02 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | 1,007 | 56.50 | $56,895.5 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.